Canopy Growth Corporation (CGC)
| Market Cap | 383.14M +128.5% |
| Revenue (ttm) | 203.04M +0.6% |
| Net Income | -238.19M |
| EPS | -0.99 |
| Shares Out | 377.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,866,562 |
| Open | 0.942 |
| Previous Close | 0.974 |
| Day's Range | 0.930 - 1.020 |
| 52-Week Range | 0.770 - 2.380 |
| Beta | 2.34 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Feb 6, 2026 |
About CGC
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7A... [Read more]
Financial Performance
In fiscal year 2025, Canopy Growth's revenue was 269.00 million, a decrease of -9.47% compared to the previous year's 297.15 million. Losses were -598.12 million, -9.00% less than in 2024.
Financial numbers in CAD Financial StatementsNews
Best Canadian Cannabis Stocks for Potential Breakouts in March 2026
The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain ...
Canopy Growth Unveils New Brand ‘Deelish': High THC, Everyday Price
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the e...
Thinking About Buying Canopy Growth Stock? You May Want to Wait for This to Happen First
Marijuana legalization in the U.S. isn't likely to happen anytime soon, and that's weighing on Canopy Growth's stock. The company's results have been abysmal, and there's little reason to be optimisti...
Canopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that its Apollo Cannabis Clinics (“Apollo”) has been named...
Canopy Growth Announces Storz & Bickel Executive Transition
SMITH FALLS, Ontario & TUTTLINGEN, Germany--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the appointment of David Männer as M...
2 Beaten-Down Stocks That Still Aren't Worth Buying
These two companies are facing nearly insurmountable challenges. Their share prices could keep on dropping over the medium term.
Canopy Growth completes takeover of MTL Cannabis
Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's shift towards the medical market.
Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue.
Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands
The global cannabis industry continues evolving as legalization slowly expands across multiple regions. Investors remain focused on companies positioned for long-term growth. Canadian cannabis produce...
Canopy Growth: Is There Any Hope Left for This Beaten-Down Stock?
Canopy Growth has struggled to generate much growth in recent years. It has continued to incur significant losses and burn through a ton of cash.
Is It Time to Dump Your Shares of Canopy Growth?
Canopy Growth is a marijuana stock trading around $1 a share. The company is acquiring another marijuana business in a cash-and-stock transaction.
Is Canopy Growth Stock Going to $0?
Canopy Growth's financial results have been unimpressive and continue to be so. Even with regulatory progress in the U.S., its outlook seems unattractive.
Is It Time to Dump Your Shares of Canopy Growth?
Marijuana stocks were all the rage a few years ago, but the excitement has faded. Canopy Growth, a major player, is still struggling to become sustainably profitable.
Are Canadian Cannabis Stocks Ready to Rebound? 3 Names to Watch
The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum...
Don't Even Think About Buying Canopy Growth Stock Until You Read This Brutal Reality Check
Canopy Growth is a money-losing marijuana start-up. The company was recently forced to recapitalize its balance sheet even as it moves forward with an acquisition.
Here's Why I Wouldn't Touch Canopy Growth With a 10‑Foot Pole in 2026
Canopy Growth grows marijuana, but it hasn't been the best steward of investor capital.
Canadian Marijuana Stock Picks For Investors 2026
There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uph...
Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker?
Don't bet on either one to pull that off.
Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) is pleased to announce that shareholders of MTL Cannabis Corp. (“MTL Cann...
Is the Market Bullish or Bearish on Canopy Growth Corp?
Canopy Growth Corp's (NYSE: CGC) short interest as a percent of float has risen 13.11% since its last report. According to exchange reported data, there are now 40.10 million shares sold short , whic...
Canopy Growth Reports In-Line Q3, But Q4 Remains Positive Despite Weak Sector
Canopy Growth Corporation reported increasing revenue for Q3 2026, but net loss persists. Medical cannabis drove the increase, while international sales decreased. The company will acquire MTL Cannabi...
Is It Time to Dump Your Shares of Canopy Growth Corp?
Sometimes, you need to know when to quit.
Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares
Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares
Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in ...
Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in a Dynamic Market
Q3 2026 Canopy Growth Corp Earnings Call Transcript
Q3 2026 Canopy Growth Corp Earnings Call Transcript